(Q30882290)

27 June 2017

title

A focused compound library of novel N-(7-indolyl)benzenesulfonamides for the discovery of potent cell cycle inhibitors (English)

1 reference

27 June 2017

Owa T

1

1 reference

27 June 2017

Okauchi T

2

1 reference

27 June 2017

Yoshimatsu K

3

1 reference

27 June 2017

Sugi NH

4

1 reference

27 June 2017

Ozawa Y

5

1 reference

27 June 2017

Nagasu T

6

1 reference

27 June 2017

Koyanagi N

7

1 reference

27 June 2017

Okabe T

8

1 reference

27 June 2017

Kitoh K

9

1 reference

27 June 2017

Yoshino H

10

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Bioorganic & Medicinal Chemistry Letters

27 June 2017

published in

1 reference

27 June 2017

volume

10

1 reference

27 June 2017

issue

11

1 reference

27 June 2017

page(s)

1223-1226

1 reference

Relations Between Structure and Biological Activity of Sulfonamides

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ET(B) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Endothelin antagonists: substituted mesitylcarboxamides with high potency and selectivity for ET(A) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Human beta3 adrenergic receptor agonists containing imidazolidinone and imidazolone benzenesulfonamides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Potent, elective human beta3 adrenergic receptor agonists containing a substituted indoline-5-sulfonamide pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Diarylsulfonamides as selective, non-peptidic thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorption

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Novel sulfonamides as potential, systemically active antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Phase I study of E7010

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

The reaction of vinyl grignard reagents with 2-substituted nitroarenes: A new approach to the synthesis of 7-substituted indoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2800%2900219-5

7 January 2021

10.1016/S0960-894X(00)00219-5

Identifiers

DOI

1 reference

27 June 2017

1 reference